Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-17

Clinical Trial Update: A Safety and Feasibility Study of Mitotane in Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 safety and feasibility study of mitotane in prostate cancer has completed, and results were posted in December 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitotane (mitotane)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-12-17